palmitoylethanolamide.com.au
HomeResearchDella 2021

Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide?

Della Rocca G, Gamba D. Animals (Basel). 2021;11(4):952.

ReviewDogsCats

Design
Review
Subjects
Narrative review
Dose used in the study
Not applicable
Duration
Not applicable
What was measured
The role of mast cells and microglia in chronic pain, and the published studies of palmitoylethanolamide in inflammatory and neuropathic pain, most of them in laboratory animals and people

What the authors reported

The evidence supports a place for micronised palmitoylethanolamide in the dietary management of chronic pain in dogs and cats, the authors say.

Limits of this study

A narrative review whose conclusion about dogs and cats rests mainly on studies in other species. Both authors are consultants to Innovet Italia, which makes veterinary PEA products; one also consults for Elanco. Open access, MDPI.

Source

PubMed 33805489 · doi:10.3390/ani11040952

Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.